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Abstract
Background: The Birt–Hogg–Dubé (BHD) syndrome is a very rare autosomal dominant form of genodermatosis
caused by germline mutations in the folliculin (FLCN) gene, which is mapped to the p11.2 region in chromosome
17. BHD commonly presents cutaneous fibrofolliculomas, pulmonary cysts, renal cell carcinoma, and recurrent
pneumothoraxes. The disease is easily ignored or misdiagnosed as pneumothorax, pulmonary lymphangiomyomatosis
(LAM), or emphysema. Follow-up and guidelines for managing recurrent pneumothoraxes in these patients are lacking.
Case presentation: We reported the case of a 56-year-old Chinese woman who presented skin lesions, multiple lung
bubblae, recurrent pneumothoraxes, thyroid nodules, and pulmonary inflammatory pseudotumors (PITs). The patient
had a family history of pneumothoraxes and renal tumor. The BHD diagnosis was confirmed by genetic testing, which
revealed a novel FLCN mutation in exon 14. Furthermore, the patient underwent a bullectomy because of recurrent
pneumothorax 6 years ago.
Conclusion: To our knowledge, the novel mutation in exon 14 and the manifestation of PIT in the present case have
never been reported for BHD. The patient underwent a bullectomy previously with no relapse at the last follow-up
before the preparation of this report, thereby suggesting that thoracotomy with bullectomy may be a possible
therapeutic approach for some BHD patients with recurrent pneumothorax.
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Background
BHD syndrome is a rare autosomal dominant form of
genodermatosis; the disease characterized by cutaneous
fibrofolliculomas, pulmonary cysts, renal cell carcinoma,
and recurrent pneumothoraxes [1]. Several other mani-
festations of BHD have been reported, such as colorectal
carcinoma and colon polyps [2–4], thyroid nodules, par-
otid oncocytomas, multiple lipomas, oral papules, and
cancer [5, 6]. However, their causal associations with
BHD have not been clinically validated.
BHD was first reported as an inherited dermatological
syndrome in 1977; the gene responsible for the syn-
drome was cloned in 2002 [7, 8]. To date, 152 unique
pathogenic FLCN gene mutations in 616 families have
been reported in worldwide; approximately 90% of these
mutations were reported in Europe and the United
States [6]. The most frequent hot spot of mutation oc-
curs in a tract of eight cytosines in exon 11 identified
in approximately 50% of BHD patients regardless of
ethnicity. Mutations in exons 9 and 12 are common,
and their association with lung cysts and pneuo-
mothoraces is statistically significant [1, 5, 9]. Multiple
bilateral pulmonary cysts occur in 70 to 84% of the
affected members in BHD families [5, 10, 11]. Approxi-
mately 30% of BHD patients will develop spontaneous
pneumothoraxes, most frequently before the age of
40 years (median age of onset, 38 years) in Europe and
the United States [10]. By contrast, multiple pulmonary
cysts with recurrent pneumothorax are observed in ap-
proximately 90% of the BHD cases in Japanese patients
[12]. Although the number of case reports describing
lung disorders has increased, data are still lacking on
the effective measures and follow-up to support the
treatment of pneumothorax in BHD.
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We reported the case of a Chinese woman with skin
lesions, multiple lung bullae, recurrent pneumothorax,
thyroid nodes, PIT, and family history of spontaneous
pneumothoraxes and renal tumor. The woman was sub-
sequently diagnosed with a novel mutation. Moreover,
the patient underwent a pulmonary bullectomy for re-
current pneumothorax 6 years ago.
Case presentation
A 56-year-old non-smoking Chinese woman visited our
hospital; she has cough, expectoration, and throat dis-
comfort for the past 45 days. The patient had no fever,
chest congestion, or chest pain. Upon physical examin-
ation, multiple white dome-shaped papules were found
on her cheek, palpebra, fossa axillaris, and back (Fig. 1).
Her medical history showed a tendency to illness. The
patient first developed pneumothorax at the age of 36,
with multiple bilateral pulmonary cysts and subsequently
underwent a tube thoracostomy. After 12 years, the
pneumothorax recurred. At 50 years of age, the patient
had a third pneumothorax; her right lung was com-
pressed by 40%. Finally, the patient consented to surgical
intervention for therapeutic purposes. During surgery,
thin-walled bullae with sizes from 0.1 cm to 3.0 cm in
diameter were observed on the right lung pleura. The
bulla over 10 cm in diameter was found in the right
horizontal fissure, and a 2.5 cm -diameter intrapul-
monary bulla containing liquid was found in the lateral
segment of the right middle lobe. Partial pleura adhe-
sions were released by an electrosurgical generator.
The 10 cm bulla was completely removed through
wedge-shaped excision. The other bubblae on the
pleura were clamped, closed and removal. The incisions
were sutured, and the thoracic wall was rubbed and
congested for pleurodesis. Histopathological examination
showed that the inner surfaces of the cysts were lined with
epithelial cells positive for CK7 and TTF-1; the cysts occa-
sionally contained internal septa consisting of alveolar
walls (Fig. 2).
The patient is a non-smoker, who easily became ill
even when she was young. Furthermore, she had a
family history of spontaneous pneumothorax. The
mother and maternal aunt of the patient had histories of
pulmonary bullae and pneumothoraxes; her mother died
of renal cancer at the age of 71, with pulmonary bubblae
and recurrent pneumothorax. Her 31-year-old daughter
and 69-year-old male cousin were classified as BHD-
unaffected because they did not show manifestations of
BHD upon physical examinations. Her maternal aunt
died in her 80s without tumor diseases, but with several
recurrent pneumothoraxes. A chest computed tomog-
raphy (CT) scan taken at our hospital showed multiple
cystic lesions throughout the lungs, mainly in the basilar
regions (Fig. 3). A 2.8 cm × 2.3 cm solid lesion was
present in the posterior basal segement of the lower
right lobe (Fig. 4), which was subsequently proven to be
a PIT by ultrasound guided percutaneous lung biopsy.
Biopsy revealed massive infiltrations of inflammatory
cells, including plasma cells and lymphocytes admixed
with fibroblasts and myofibroblasts (Fig. 5). Immunohis-
tochemical studies showed positive reactions for CD3,
CD20, and Ki-67, whereas no staining was observed with
antibodies against CEA, IgG4, IgG, and ALK. These
findings were reported as fibrous changes at the same
location in the CT performed previously (Fig. 4a, c).
Ultrasound examination showed that the patient did not
develop a renal carcinoma, but multiple thyroid nodules
had emerged.
Given that the patient had multiple skin papules,
cystic lesions, pneumothorax, and a family history of
pneumothorax and renal tumor, we suspected a
congenital disease, particularly BHD. Therefore, we per-
formed blood DNA analysis, and four mutations were
identified (Table 1). A mutation of T to C (c.2297 T > C)
in exon 14 leads to the change from Phe to Ser
(p.Phe766Ser). To our knowledge, this mutation has
never been reported before (Fig. 6). Besides the muta-
tion in exon 14, we also detected a mutation in exon 1
(c.-299C > T) with a mutation rate of 0.42. Another mu-
tation in intron 8 (c.871 + 36G > A), with a mutation
rate of 0.17, causes the codon 303 mutation (p.G
ly303Arg) in FLCN 2 transcription. The third mutation
in intron 9 (c.1062 + 6C > T) has mutation rate of 0.66.
However, these three mutations were previously re-
ported to have a minimal correlation to the onset of
BHD [13].
Fig. 1 Multiple pale and dome-shaped macules over the patient’s
face, which are characteristic skin lesions of BHD syndrome
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Discussion and conclusion
BHD syndrome is difficult to diagnose at initial evalu-
ation because of its low morbidity and variable manifes-
tations. BHD is not yet well-known in East Asia,
particularly in China. BHD is a rare type of genoderma-
tosis and an autosomal dominant disease caused by
FLCN mutations. To date, 90% of the reported BHD pa-
tients are from Europe and the United States; 82 to 92%
of the cases in these regions have characteristic skin
symptoms. By contrast, the rate of characteristic symp-
toms is 20 to 29% in Japanese patients, which may ac-
count for the relative difficulty to recognize the disease;
the clinical manifestations of BHD may have potential
racial differences [6, 14, 15]. Recurrent pneumothorax is
observed in approximately 90% of Asian patients [12],
which is higher by 60% than in Western countries.
Fig. 2 Histopathological features of the resected lung specimens from the patient 6 years ago. Cysts are indicated by stars. a These cysts are
incorporated with interstitial stroma of the interlobular septum or pleura (hematoxylin–eosin–safranin staining). Cysts lined by b CK7+ and
c TTF-1+ pneumocytes. d D2-40 is negative in the lining (thin arrows) but positive in lymphatics (thick arrow)
Fig. 3 Postoperative changes are shown in the right lung. a, c The previous CT scan shows numerous cysts in the lung bases; one dominant cyst
measures 8.4 cm × 5.1 cm in the right lung and contains some liquid; another huge cyst is anterior to the heart (white arrow). b, d The right lung
expanded well after the operation with no obvious scar or atelectasis. Some cysts remained stable (black arrow) or became even smaller
(white arrow). However, more cysts appeared in the lung bases (thick arrow)
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However, BHD is easily misdiagnosed as cystic lung dis-
ease, particularly LAM, Langerhans cell histiocytosis,
and lymphocytic interstitial pneumonia.
Imaging studies may facilitate differential diagnosis.
Cysts in BHD cases are round or oval, withthin, visible,
and uniform walls. The cysts are typically located in the
basilar and mediastinal lung regions, which differ from
the typical apical location of smoking-related emphy-
sema and bullae in primary spontaneous pneumotho-
raxes [16]. The number and size of the cysts are
variable; cysts less than 1 cm in diameter are most com-
monly seen [17]. We confirmed these findings in the
present patient (Fig. 3). LAM is the most difficult to dif-
ferentiate from BHD, particularly when associated with
cutaneous and renal involvement. Cysts in BHD and
LAM are thin walled, but those in LAM are smaller,
more circular, and equally distributed [16, 18]. On the
other hand, the prognosis of BHD is better. LAM usually
progresses to respiratory insufficiency with increasing
lung cysts. However, BHD typically does not result in re-
spiratory failure.
Little is known about the development of pulmonary
cysts in BHD patients. Some reviews suggest that nu-
merous cysts appear to remain stable or unruptured be-
cause the frequency of pneumothorax in elderly BHD
cases is not as high as that in middle-aged patients [19].
In the present case, we compared the CT findings. Some
bullae of the right lung were removed by bullectomy
5 years ago without any scars or atelectasis in the recent
CT. The changes were evident in the lungs. Some bullae
remained stable, whereas others were absorbed as they
shrank or disappeared. However, bullae at the bottom
became larger (Fig. 3). The pathological findings of the
cysts in BHD are non-specific [20], which is also true in
the present case (Fig. 2). Almost 15 years have passed
since the discovery of FLCN, and increasing numbers of
BHD cases have been reported. However, follow-up of
these affected patients is still needed.
Fig. 4 Chest CT scan with pulmonary pseudotumor. a Previous CT scan shows a fibrous change in the same slice. b The present CT scan shows a
2.8 cm × 2.3 cm pulmonary solid lesion with irregular margins and adjacent pleural thickness. c, d Corresponding mediastinal window
Fig. 5 Ultrosound-guided needle biopsy of the lung lesion with immunohistochemistry showed that it is positive for an inflammatory pesudotumor
with a extensively hyperplasic fibrous and inflammatory cell infiltration, and b necrosis lung tissues
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Our case report described a novel mutation in FLCN,
and a new manifestation of PIT in lung lesions of BHD.
Previous studies showed that FLCN serves as a tumor
suppressor gene. The germline mutations in FLCN are
related to BHD pathogenesis. However, clear genotype–
phenotype associations have not been reported in BHD
[4, 21]. PIT is an uncommon benign lesion in the lungs;
this lesion is considered to be an inflammatory or
reactive lesion rather than a neoplasm. The exact
etiology is unknown, and an immune disorder seems
to be an acceptable hypothesis. In the present patient,
the poor condition of the lungs, with multiple cysts,
recurrent pneumothoraxes, and tube thoracostomy,
disturbed the pulmonary immunity, thereby making it
easily infected. However, these conditions also exist in
other BHD patients who did not develop a PIT. The
only difference is that the patient in the present case
has a novel mutation in FLCN. Given that the exact
etiology of PIT is unknown and no exact genotype–
phenotype associations of BHD have been reported,
more data are still needed.
The correlation of the new manifestation in this pa-
tient with the new mutation has not been confirmed.
The patient also showed multiple thyroid nodules, which
were also reported in almost half of the BHD patients.
This patient did not develop any renal tumors at the last
follow-up. The patient’s mother died of a renal tumor.
Renal tumors are present in 27% of the BHD patients
[21]. Therefore, we informed the patient of the possi-
bility that she could be affected by a renal tumor and
suggested that she undergo abdominal ultrasound
scan or CT annually.
The occurrence of multiple bilateral pulmonary cysts
and spontaneous pneumothorax is high in BHD patients
[5, 10, 11]. The management of BHD from a pulmonary
perspective is focused on the treatment of pneumo-
thorax. Conservative measures (observation, aspiration,
and tube thoracostomy) are taken to manage the initial
pneumothorax, which is usually undiagnosed during
the first instance. However, BHD patients still face a
high risk of recurrent pneumothorax, thereby making
these patients anxious. Video-assisted thoracoscopy
and mechanical or chemical pleurodesis are typically
reserved for recurrent or non-healing cases [16, 22],
which make it difficult for reoperation and thoracic sur-
geries in later years. A unique method was reported to
Table 1 Summary of total mutations identified in the FLCN gene by sequencing
dbSNP mRNA positiona Location or △AAa Allelesa Minor Allele MAF in CHB
rs1708629 c.-299 5′UTR C > T C 0.42
rs3744124 c.871 + 36 Intron 8 G > A G 0.17
rs8065832 c.1062 + 6 Intron 9 C > T C 0.66
p.F766S c.2297 Exon 14 T > C T None
△AA change in amino acid, MAF minor allele frequency, CHB samples from Han Chinese in Beijing, China studied in Hapmap project
aReferenced to the positive strand and folliculin isoform 1 [GenBank: NM_144997]
Fig. 6 Identification of a germline heterozygous FLCN mutation in the patients. The result showed a heterozygous mutation in exon 14 resulting
in an animo acid transformation of phenylalanine into serine (p.Phe766Ser)
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prevent recurrent pneumothorax without adhesion to
the chest wall, as well as total or partial pleural covering;
however, success is heavily dependent on local expertise
[23, 24]. Although the number of case reports on lung dis-
orders has increased, data collection on effective measures
and follow-up are still lacking to support the treatment of
pneumothorax in BHD.
We reported the case of a Chinese woman who under-
went pulmonary bulla resection 6 years ago and did not
have a recurrent pneumothorax at the last follow-up.
Adequate management of bullae on the pulmonary sur-
face, thoracic wall congestion, and hemorrhage during
surgery favored the adhesion between the visceral and
parietal pleura, thereby contributing to the success of
the operation.
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